UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference
A live audio webcast will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.
About UNITY
UNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.
Investors & MediaAustine Graff Unity Biotechnology 650-443-6725 Austine.Graff@unitybiotechnology.com
Source: Unity Biotechnology, Inc.